At the European Cancer Congress (ECC) 2015, Grant McArthur, MBBS, BMedSc, PhD, FRACP, of the Peter MacCallum Cancer Centre, Victoria,…
Browsing: Acute Lymphoblastic Leukemia
At the European Cancer Congress (ECC) 2015, Eric Pujade-Lauraine, MD, PhD, of Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris,…
At the European Cancer Congress (ECC) 2015, Dirk Schadendorf, MD, PhD, of Universitätsklinikum Essen, Essen, Germany, discusses the advances in…
Multigene assays may provide clinically complementary information to classic clinicopathological tumour features, such as tumour size and grade, in breast…
The Oncotype DX® Breast Cancer Assay, a multigene assay, stratifies breast cancer patients into groups that are at low, intermediate…
At the European Cancer Congress (ECC) 2015, Benjamin Besse, MD, PhD, of Institut Gustave Roussy, Villejuif, France, discusses BIRCH, a…
At the European Cancer Congress (ECC) 2015, Bartomeu Massuti, MD, of Hospital General de Alicante, Alicante, Spain, discusses the Spanish…
At the European Cancer Congress (ECC) 2015, Georgina Long, BSc, PhD, MBBS, FRACP, of The University of Sydney, Sydney, Australia,…
@OncEd Presents Dr. Enriqueta Felip – Targeted therapies in ALK-positive NSCLC
@OncEd Presents Dr. Simon Raphael – Actionable biomarkers in NSCLC: EGFR and ALK
@OncEd Presents Dr. Keith Flaherty – Integrating new treatment options for melanoma
@OncEd Presents Dr. Keith Flaherty – An expert’s perspective on frequently asked questions on BRAF V600-mutated advanced melanoma
@OncEd Presents – Dr. Natasha Leighl & Dr. David Hogg – Immune Response Vs. RECIST Criteria
@OncEd Presents Dr. Lori Wood – Optimizing Outcomes in Advanced Prostate Cancer
Chris Carrigan of the National Cancer Intelligence Network (NCIN), discusses the uses of the enormous amount of data collected by…
Karen Kennedy, PhD, Director of the National Cancer Research Institute (NCRI), gives an overview of the 2015 NCRI Cancer Conference.…
Kristian Helin, PhD gives an overview of his talk on epigenetic targets in cancer presented at the 2015 National Cancer…
Robert Coleman, MBBS, MD, FRCP, a trustee of Breast Cancer Now, discusses the goals of the newly formed charity that…
Kevin Brindle, PhD gives an overview of his talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, where…
Harpal Kumar, MA MEng MBA DSc gives an overview of his session at the 2015 National Cancer Research Institute (NCRI)…
Miriam Johnson, MD gives an overview of a session at at the 2015 National Cancer Research Institute (NCRI) Cancer Conference,…
With the advent of unlocking genetic code, the cancer community has now been introduced to the concept of immunotherapy. What…
In this segment of The Conversation, MPN Edition, Dr. Srdan Verstovsek of MD Anderson Cancer Center, MPN expert Dr. Mark…
CLL patients with certain genetic markers are considered to be high risk and their options for treatment have historically been…
MPN experts Dr. Mark Heaney of Columbia University Cancer Center and Dr. Srdan Verstovek of MD Anderson Cancer Center examine…
Dr. Michael Keating, a leading researcher from MD Anderson Cancer Center, has had a career that spans decades and has…
Paolo Boffetta, MD, MPH gives an overview of his talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference.…
Rebecca Fitzgerald, MD, FAAD gives an overview of a session presented at the 2015 National Cancer Research Institute (NCRI) Cancer…
Chad Creighton of the Baylor College of Medicine: “How does the Papillary RCC: The Cancer Genome Atlas (TCGA) impact Physicians?”
Chad Creighton of Baylor College of Medicine discusses the next steps for Papillary RCC: The Cancer Genome Atlas (TCGA)
Chad Creighton of Baylor College of Medicine discusses a short overview of the Papillary RCC: The Cancer Genome Atlas (TCGA)
Tim Hunt, FRS, FMedSci describes the path that led him to identify cyclin-dependent kinases (CDK), along with colleagues Paul Nurse…
Jack Cuzick, PhD, FMedSci, FRCP(hon), of the Queen Mary University of London, UK gives an overview of the session ‘Prevention…
In the session ” Tumour: stroma interactions” presented at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, the importance…
Clare Turnbull, MD, PhD, gives an overview of her talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference,…
Neeraj Agarwal, MD of the Huntsman Cancer Institute presents “Molecular predictors of response and survival outcomes in patients with metastatic…
Michael A. Gorin, M.D. of Johns Hopkins University School of Medicine presents “Development of an Antibody-free Method for Detecting Renal…
David Gill, MD of the Huntsman Cancer Institute presents “Correlation of tumor programmed death ligand-1 (PD-L1) expression and response to…
Peter F. Thall, PhD of M.D. Anderson Cancer Center presents “Bayesian Designs for Early Phase Clinical Trials” at the 14th…
Meredith M. Regan, ScD of the Dana-Farber Cancer Institute presents “Statistical Considerations in RCC: Biomarker-Based Studies” at the 14th International…
Wayne A. Marasco, MD, Ph.D.of the Dana-Farber Cancer Institute presents “Carbonic Anhydrdase IX: Opportunities for Immune-Based Approaches” at the 14th…
Daniel Lindner, MD, PhD of the Cleveland Clinic presents “Patient derived xenograft models and ? potential therapeutic applications” at the…
Thai Ho, M.D., Ph.D. from the Mayo Clinic Arizona presents “The Evolving Role of Chromatin and Epigenetics in RCC” at…
Sumanta Kumar Pal, M.D. of the City of Hope Comprehensive Cancer Center presents “Applying Advanced Genomics to Therapy Selection” at…
Brian Rini, MD of the Cleveland Clinic presents “2015 Eugene P. Schonfeld Award” at the 14th International Kidney Cancer Symposium.
Eliezer (Eli) Van Allen, MD of Dana-Farber Cancer Institute presents “Expanding the clinically actionable kidney cancer genome” at the 14th…
Brian R. Lane, M.D., Ph.D., FACS of Spectrum Health Medical Group? presents “Molecular Prediction of Kidney Cancer Recurrence”
Thai Ho, M.D., Ph.D. from the Mayo Clinic Arizona presents “KCA Role in Developing a Research Program in Kidney Cancer…
André P. Fay, MD of Dana-Farbe presents “Treatment of Kidney Cancer in Developing Countries ” at the 14th International Kidney…
Thomas E Hutson, DO, PharmD, FACP of the Baylor-Sammons Cancer Center presents “Emerging Targeted Therapies” at the 14th International Kidney…